5.340USD-6.48%Mkt Cap: 33.05M USDP/E: —Last update: 2026-06-01
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap33.05M USD
Enterprise Value-15.28M USD
Revenue (TTM)4.71M USD
Gross Profit-64.75M USD
Net Income (TTM)-24.19M USD
Revenue/Share0.4530 USD
Last Price5.340 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees82
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS01626L1052
Valuation
P/E (Trailing)—
P/E (Forward)-1.42
PEG—
EV/EBITDA0.16
EV/Revenue-3.25
P/S7.50
P/B1.11
EPS (TTM)-9.78
EPS (Forward)-4.00
52W Range
5.1203% of range13.69
52W High13.69 USD
52W Low5.120 USD
Profitability
Gross Margin0.00%
Oper. Margin-951.55%
EBITDA Margin0.00%
Profit Margin-1106.72%
ROE-45.18%
ROA-27.33%
Growth
Revenue Growth810.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-82.50M USD
CapEx (TTM)437.00K USD
FCF Margin-1048.68%
FCF Yield-149.31%
Net Debt-50.56M USD
Net Debt/EBITDA0.53
Balance Sheet
Debt/Equity0.10
Current Ratio2.56
Quick Ratio2.35
Book Value/Sh5.137 USD
Cash/Share8.873 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateAug 19, 2024
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)56.29 USD
Target Range20.00 USD – 175.00 USD
# Analysts7
Ownership
Shares Out.5.39M
Float3.64M
Insiders10.30%
Institutions55.08%
Short Interest
Short Ratio1.2d
Short % Float10.19%
Short % Out.8.65%
Shares Short535.18K
Short (prev mo.)275.69K
Technical
SMA 506.704 (-20.3%)
SMA 2008.385 (-36.3%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)144.37K
Avg Vol (10d)139.36K
Technical Indicators
RSI (14)43.3
MACD-0.2951
MACD Signal-0.3109
MACD Hist.+0.0158
BB Upper6.880 USD
BB Middle5.993 USD
BB Lower5.107 USD
BB Width29.58%
ATR (14)0.4894 USD
Vol Ratio (20d)0.64x